Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Main pharmacokinetic parameters of daidzein after rats were orally administered with DLCL and daidzein (mean ± SD, n = 5)

From: Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes

Parameter Unit Daidzein group DLCL group
AUC0−t μg/L*h 647.95 ± 166.43* 1515.52 ± 532.40
AUC0− μg/L*h 650.33 ± 166.53* 1606.64 ± 554.69
MRT0−t h 7.81 ± 1.12* 12.51 ± 2.63
t 1/2 h 4.83 ± 1.06* 8.70 ± 3.342
T max h 0.20 ± 0.045* 0.12 ± 0.053
C max μg/L*h 316.39 ± 87.76 355.05 ± 38.96
  1. *p < 0.05 vs daidzein group